Literature DB >> 18693093

Hand function after high dose rate brachytherapy for squamous cell carcinoma of the skin of the hand.

B V Somanchi1, A Stanton, M Webb, J Loncaster, E Allan, L T S W Muir.   

Abstract

AIMS: Current recommendations for the treatment of squamous cell carcinoma of the hand are almost unanimously in favour of ablative surgery. However, many of the patients are frail and elderly, and surgical techniques frequently involve skin grafts or amputation of digits. A non-invasive method of treatment is, therefore, often preferred. Radiotherapy using a brachytherapy technique is a well-established option. This study investigated whether patients found the treatment acceptable and assessed the outcome of treatment in terms of local control, cosmesis and hand function.
MATERIALS AND METHODS: Twenty-five patients who underwent mould brachytherapy using a microselectron high dose rate radiotherapy device were available for assessment. We assessed the functional status of the hand and fingers by means of the Disability of Arm, Shoulder and Hand and Michigan Hand Outcomes questionnaires. We examined the hand to assess the severity of post-radiation stigmata. We enquired as to patient acceptability of treatment and outcome.
RESULTS: Of 25 patients who agreed to participate, the fingers were affected in 15 and the dorsum of the hand in 10. The mean age at the time of radiotherapy was 69 years (range 50-87). There were no significant differences in parameters, such as range of motion of fingers and wrist, hand/finger grip strength, between the treated and opposite sides. Sensation, including two-point discrimination, was not significantly different from the untreated hand. Seventeen patients had minor skin changes. No patient found the treatment painful or unacceptable. Twenty patients were very satisfied and five patients were moderately satisfied with the cosmetic result.
CONCLUSIONS: We conclude that high dose rate brachytherapy is a safe and simple alternative to surgical treatment for squamous cell carcinoma of the hand, as it is not only successful in eradicating tumour, but also preserves hand function.

Entities:  

Mesh:

Year:  2008        PMID: 18693093     DOI: 10.1016/j.clon.2008.06.008

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  6 in total

1.  Radiotherapy treatment of non-melanoma skin cancer: a survey of current UK practice and commentary.

Authors:  A J McPartlin; N J Slevin; A J Sykes; A Rembielak
Journal:  Br J Radiol       Date:  2014-09-05       Impact factor: 3.039

Review 2.  The State of the Art of Radiotherapy for Non-melanoma Skin Cancer: A Review of the Literature.

Authors:  Sofian Benkhaled; Dirk Van Gestel; Carolina Gomes da Silveira Cauduro; Samuel Palumbo; Veronique Del Marmol; Antoine Desmet
Journal:  Front Med (Lausanne)       Date:  2022-06-27

3.  Skin CanceR Brachytherapy vs External beam radiation therapy (SCRiBE) meta-analysis.

Authors:  Nicholas G Zaorsky; Charles T Lee; Eddie Zhang; Thomas J Galloway
Journal:  Radiother Oncol       Date:  2018-01-19       Impact factor: 6.280

4.  High-dose-rate (HDR) plesiotherapy with custom-made moulds for the treatment of non-melanoma skin cancer.

Authors:  Angel Montero; Raúl Hernanz; Ana-Belén Capuz; Eva Fernández; Asunción Hervás; Rafael Colmenares; Alfredo Polo; Sonsoles Sancho; Rafael Molerón; Carmen Vallejo; Alfredo Ramos
Journal:  Clin Transl Oncol       Date:  2009-11       Impact factor: 3.405

5.  Long-term remission after low dose radiotherapy in patient with extensive squamous cell carcinoma of the hand: A case report.

Authors:  Timothy Cheo; Ivy Ng; Kiat Huat Ooi; Bok Ai Choo
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

6.  Combined interstitial and surface high-dose-rate brachytherapy treatment of squamous cell carcinoma of the hand.

Authors:  Daniel W Kim; Ivan M Buzurovic; Brandon V Mahal; William Hwang; Oluwadamilola T Oladeru; Desmond A O'Farrell; Thomas C Harris; Danielle N Margalit; Miranda Lam; Phillip M Devlin
Journal:  J Contemp Brachytherapy       Date:  2020-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.